Metabolism of remifentanil during liver transplantation.
We have investigated the pharmacokinetics of remifentanil and its less potent metabolite, GR90291, in six adult patients undergoing orthotopic liver transplantation (OLT). A single bolus infusion of remifentanil 10 micrograms kg-1 min-1 was given at the beginning of the dissection and anhepatic phases of OLT. Remifentanil and GR90291 concentrations were measured in subsequent serial arterial and mixed venous blood samples. Mean arterial clearance of remifentanil was significantly greater (P = 0.02) in the dissection phase (79.54 ml min-1 kg-1) than in the anhepatic phase (39.57 ml min-1 kg-1). Steady state volumes of distribution were not significantly different. Clearance of remifentanil during the anhepatic phase was similar to that of healthy adult patients. Mean maximum concentration (Cpmax) of GR90291 was lower in the dissection phase than in the anhepatic phase (P = 0.026). There was no significant pulmonary metabolism of remifentanil.
Navapurkar
V U
VU
John Farman Intensive Care Unit, Addenbrooke's Hospital, Cambridge.
Archer
S
S
Gupta
S K
SK
Muir
K T
KT
Frazer
N
N
Park
G R
GR
D000293:Adolescent; D000328:Adult; D000701:Analgesics, Opioid / Q000097:blood* / Q000493:pharmacokinetics; D005260:Female; D006207:Half-Life; D006801:Humans; D007430:Intraoperative Care; D016031:Liver Transplantation; D008168:Lung / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000097:blood* / Q000493:pharmacokinetics; D000077208:Remifentanil
D000701:Analgesics, Opioid; D010880:Piperidines; C084032:GI 90291; D000077208:Remifentanil